Published in Cancer Weekly, October 27th, 1997
Uveal melanoma results in the death of half of those afflicted with this tumor. Despite therapeutic advances, little progress has been made in reducing mortality associated with this disease. Intraocular melanomas are highly metastatic in general, and it is this metastatic process that eventually kills the patient.
Several proteases are associated with tumor invasion and metastasis, however, plasminogen activators (PA) have received the most attention. PAs are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.